Answers are grounded in this paper and cite their sources.
Introduction: This systematic review assesses whether pharmacy services improve clinical outcomes and quality of life in pediatric patients assisted in community settings and community pharmacies outside the hospital environment. Methods: Two independent reviewers searched the Cochrane Library, MEDLINE, EMBASE and LILACS databases, as well as ongoing studies in ClinicalTrials.gov, ICTRP and ReBEC, up to July 2022, with no language or publication date restrictions. The review was registered in PROSPERO (CRD42018105742). Randomized and cluster-type clinical trials involving participants aged 0–18 years using any medication and receiving pharmacist interventions in referral centers, hospital outpatient clinics or community pharmacies were included. Results: Among 54 identified articles, 6 met inclusion criteria, addressing conditions such as asthma, thalassemia, diabetes and care for hemodialysis patients, totaling 695 participants. Five studies showed positive clinical outcomes associated with pharmacist intervention, while one study reported non-significant changes. Multiple outcomes were assessed, with a notable reduction in emergency department visits among intervention groups, supported by meta-analysis findings. Conclusions: The limited number of available studies highlights the need for further research; however, current evidence suggests that pharmacist interventions may improve clinical outcomes and quality of life in pediatric patients in community settings. This represents the most robust evidence currently available on the topic.
No takes yet. Share an insight, caveat, or question.
Costa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: